Beacon Bridge Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Beacon Bridge Wealth Partners's ABBV Position: Q2 2025 in Review
Beacon Bridge Wealth Partners sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,631 shares — an estimated $342K sold.
Beacon Bridge Wealth Partners first reported a position in ABBV in Q4 2022 and held it in 10 quarters. The position peaked at $464K in Q1 2023. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.
- Beacon Bridge Wealth Partners reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
- Beacon Bridge Wealth Partners sold 1,631 AbbVie shares in Q2 2025, an estimated $342K.
- Beacon Bridge Wealth Partners first reported a position in AbbVie in Q4 2022 and held it in 10 quarters.
- Beacon Bridge Wealth Partners's AbbVie position peaked at $464K in Q1 2023.
- 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.
Based on Beacon Bridge Wealth Partners's 13F filing for Q2 2025, filed 24 Jul 2025.